We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

FVRR:NYSEFiverr International Ltd. Analysis

Data as of 2026-04-05 - not real-time

$10.03

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Fiverr (FVRR) is trading at $10.03, well below its 20‑day SMA of 10.39 and the 200‑day SMA of 20.34, indicating a bearish price trend. The RSI of 36 suggests the stock is approaching oversold territory, while the MACD shows a bullish crossover (line above signal), hinting at a possible short‑term rebound toward the $11.33 resistance. Fundamentally, the company appears markedly undervalued – the DCF fair value is $46.25, implying a 59% upside, and the forward PE of 4.66 is far below the industry average PE of 17.34. Revenue grew modestly 3.4% year‑over‑year to $430.9 M, with gross margins near 82% and operating margins improving to ~5%, supported by a strong cash balance of $283 M and minimal debt. However, total active buyers have declined, and earnings estimates have been cut, contributing to a Zacks Rank 5 Strong Sell and heightened market skepticism. The stock’s 30‑day volatility of 54% and beta near 1 signal substantial price swings, while its liquidity is moderate with stable volume. Overall, the valuation gap and improving profitability provide a compelling upside thesis, but the bearish technical backdrop and recent earnings guidance revisions temper confidence.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 5/10

Key Factors

  • Price near support at $9.67
  • Bullish MACD crossover
  • High short‑term volatility

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • DCF upside of ~59% to $46.25
  • Forward PE of 4.66 vs industry PE 17.34
  • Strong cash position and low debt

Long Term

> 3 years
Neutral
Model confidence: 6/10

Key Factors

  • Revenue growth modest at 3.4%
  • Strategic initiatives (ads, subscription, talent platform)
  • Geopolitical and regulatory exposure in Israel

Key Metrics & Analysis

Financial Health

Revenue Growth3.40%
Profit Margin4.87%
P/E Ratio17.9
ROE5.42%
ROA1.23%
Debt/Equity1.01
P/B Ratio0.9
Op. Cash Flow$104.6M
Free Cash Flow$88.5M
Industry P/E17.3

Technical Analysis

TrendBearish
RSI36.1
Support$9.67
Resistance$11.33
MA 20$10.39
MA 50$12.49
MA 200$20.34
MACDBullish
VolumeStable
Fear & Greed Index78.8

Valuation

Fair Value$46.25
Target Price$16.00
Upside/Downside59.52%
GradeUndervalued
TypeBlend

Risk Assessment

Beta0.97
Volatility54.51%
Sector RiskMedium
Reg. RiskLow
Geo RiskHigh
Currency RiskMedium
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.